Cingulate CFO Louis G. Van Horn Retiring >CING
By Dean Seal The chief financial officer of Cingulate retired this week amid an exodus of officers and board members. The clinical stage biopharmaceutical...
Source: marketwatch.com
📰 Shane Schaffer News
Shane Schaffer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Shane Schaffer. Real-time updates on events, politics, business and more.
Cingulate Shares Hit Record Low After Exodus of Officers, Directors
By Dean Seal Shares of Cingulate tumbled to an all-time low after the company disclosed that several officers and directors have departed amid major...
Source: marketwatch.com
Cingulate and Indegene announce agreement for lead ADHD drug
An agreement has been reached to promote Cingulate Inc’s ‘first true entire active day medication’ designed to treat attention deficit hyperactivity disorder (ADHD).
Timothy Moore Shane Schaffer Drink Administration Drug Delivery Clinical Development Markets Amp Regulations
Source: outsourcing-pharma.com